ROYAL BANK OF CANADA - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,000
-43.5%
5,501
+53.9%
0.00%
Q2 2023$23,000
+91.7%
3,574
+73.0%
0.00%
Q1 2023$12,000
-70.0%
2,066
-47.3%
0.00%
Q4 2022$40,000
+471.4%
3,919
+846.6%
0.00%
Q3 2022$7,000
+133.3%
414
+117.9%
0.00%
Q2 2022$3,000
-88.5%
190
-88.4%
0.00%
Q1 2022$26,000
-79.4%
1,634
-72.3%
0.00%
Q4 2021$126,000
+447.8%
5,901
+271.1%
0.00%
Q3 2021$23,000
+27.8%
1,590
+72.5%
0.00%
Q2 2021$18,0009220.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders